Opioid Induced Constipation Market: Approved Drugs and MOA, Regulatory Milestones, Product Deve

LAS VEGAS - Dec. 15, 2021 - PRLog -- DelveInsight's "Opioid Induced Constipation Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Opioid Induced Constipation , historical and forecasted epidemiology as well as the Opioid Induced Constipation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Opioid Induced Constipation is a specific type of constipation caused by Opioids - a type of prescription pain medication. Opioids block pain signals by attaching to receptors found throughout the nervous system. However, when opioids bind to receptors in the gut, the amount of time required by the stools to pass through the gastrointestinal system is prolonged, thus inducing constipation.

Some of Opioid Induced Constipation Companies:

• Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
• Shionogi Inc.
• HealthCore, Inc.
• Ironwood Pharmaceuticals, Inc.
• And many others

Opioid Induced Constipation Therapies Covered:

• Methylnaltrexone (MNTX)
• Naldemedine
• Lubiprostone
• Linaclotide 290 micrograms
• And Many Others

Request For Opioid Induced Constipation Market Report:
https://www.delveinsight.com/report-store/opioid-induced-constipation-market (https://www.delveinsight.com/report-store/opioid-induced-...)

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sheeran S.
Email: info@delveinsight.com
Phone: +19193216187
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/